Company intelligence / Profile preview
Yabao Pharmaceutical Group Co., Ltd.
Yuncheng, Shanxi, Chinayabao.com.cn ↗
- Ownership
- Private
- Employees
- ~5600
- Development stage
- Other
01
Overview
The company has multiple approved products including Chlorquinaldol for Acne Vulgaris and Povidone-Iodine for Vulvovaginal Candidiasis. They also have several products in clinical development, including Phase 3 Neiyi Tongjing Granules for Dysmenorrhea, Phase 2 Xingshen Huayu Dropping Pills for Acute Ischemic Stroke, and Phase 2 Recombinant human annexin 5 protein for Sepsis.
- Therapeutic areas
- Infectious DiseasesEndocrinologyDermatologyNeurologyWomen's Health
- Modalities
- Small molecule drugsHerbal medicineBispecific antibodyFusion protein
- Industry
- Biotech
02
Drug pipeline
20 assets19 more assets in the full pipeline.
03
Partnerships
Eli Lilly and CompanySciecure Pharma
Beyond the preview
Go deeper on Yabao Pharmaceutical Group Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yabao Pharmaceutical Group Co., Ltd..